Mass Loss in Population II Red Giants: an IRAC@Spitzer Survey of Galactic Globular Clusters

With the goal of studying ML along the RGB, mid-IR observations of a carefully selected sample of 17 Galactic globular clusters (GGCs) with different metallicity and horizontal branch (HB) morphology have been secured with IRAC on board Spitzer: a global sample counting about 8000 giant has been obtained. Suitable complementary photometry in the optical and near-IR has been also secured in order to properly characterize the stellar counterparts to the Spitzer sources and their photospheric parameters. Stars with color (i.e. dust) excess have been identified, their likely circumstellar emission quantified and modelled, and empirical estimates of mass loss rates and timescales obtained. We find that mass loss rates increases with increasing stellar luminosity and decreasing metallicity. For a given luminosity, we find that ML rates are systematically higher than the prediction by extrapolating the Reimers law. CMDs constructed from ground based near-IR and IRAC bands show that at a given luminosity some stars have dusty envelopes and others do not. From this, we deduce that the mass loss is episodic and is ``on'' for some fraction of the time. The total mass lost on the RGB can be easily computed by multiplying ML rates by the ML timescales and integrating over the evolutionary timescale. The average total mass lost moderately increases with increasing metallicity, and for a given metallicity is systematically higher in clusters with extended blue HB.

Characterization of circulating steroids and endocannabinoids levels in obese subjects by liquid chromatography tandem mass spectrometry

Nowadays obesity can be defined as a global epidemic. The precise identification of circulating biomarkers involved in this pathology could be essential to early diagnose potential co-morbidities and to better address the development of future therapeutic strategies. Published evidences show that circulating steroid hormones and endocannabinoids might have a role in the physiopathology of obesity; however, a precise and reliable quantification of these molecules is still lacking. In the first part of the present thesis, we developed a sensitive, specific and accurate quantification method for nine steroid hormones using a liquid chromatography tandem mass spectrometry (LC-MS/MS) system. This method has been used first for a comparative study with immunoassays, currently used in the clinical practice to quantify these molecules and then to redefine circulating reference intervals in healthy subjects. Furthermore, we measured circulating steroid hormones in three groups of subjects: normo-weight, over-weight and obese, defining different steroid hormones profiles depending on the obesity state. The role of circulating endocannabinoids in humans is still unclear, however there are several evidences concerning their involvement in obesity. In the second part of the thesis, we determined changes of circulating endocannabinoids in obese patients after a weight loss induced by bariatric surgery, currently the most effective long-term treatment for obesity, using LC/MS-MS. We measured basal and dynamic endocannabinoids plasma levels in 12 patients with severe obesity before, one month after and six months after the Roux-en-Y gastric bypass intervention, currently one of the most performed types of bariatric surgery. All together the findings illustrated in this thesis project will help better define the role of steroid hormones and endocannabinoids in the framework of obesity in humans and the role that each type of molecule might have in its pathophysiology.